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Abstract
Background: The association between ST-segment resolution and clinical outcome in pa-
tients with acute ST-segment elevation myocardial infarction (STEMI) after primary percuta-
neous coronary intervention (PPCI) remains unclear. Recent studies on the association be-
tween ST-segment resolution and mortality have given conflicting results. We undertook this
study to assess whether ST-segment resolution in electrocardiograms recorded 90–120 min
after initiation of PPCI predicts long-term mortality in patients with STEMI.
Methods: The study included 900 patients with STEMI presenting within the first 24 h after
symptom onset who were treated with PPCI. The ST-segment resolution was assessed in
electrocardiograms recorded 90–120 min after the first balloon inflation. The ST-segment
resolution was dichotomized as follows: < 30% (no resolution), 30% to £ 70% (partial
resolution) and > 70% (complete resolution). The primary endpoint was five-year mortality.
Results: ST-segment resolution was < 30% in 263 (29.0%) patients, between 30% and
£ 70% in 356 (40.0%) patients and > 70% in 281 (31.0%) patients. There were 62 deaths
during the follow-up. In patients with ST-segment resolution < 30%, 30 to £ 70% and
> 70%, the Kaplan-Meier estimates of mortality were 8.3% (n = 17 deaths), 11.5% (n = 29
deaths) and 6.8% (n = 16 deaths), respectively; unadjusted hazard ratio (HR) = 0.88, 95%
confidence interval (CI) 0.46–1.67, p = 0.695 for ST-segment resolution > 70% vs < 30%;
adjusted HR = 0.91, 95% CI 0.61–1.33; p = 0.607, for ST-segment resolution > 70% vs
ST-segment resolution < 30%.
Conclusions: In patients with STEMI undergoing PPCI, ST-segment resolution in electro-
cardiograms recorded 90–120 min after initiation of PPCI did not predict long-term mortality.
(Cardiol J 2012; 19, 1: 61–69)
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Introduction
Previous studies have convincingly demon-
strated that ST-segment elevation resolution is an
important predictor of increased risk of death and
congestive heart failure in patients with acute ST-
-segment elevation myocardial infarction (STEMI)
treated with fibrinolytic therapy [1, 2]. The current
theory holds that ST-segment resolution or reco-
very after reperfusion therapy signifies effective mi-
crovascular perfusion [3], myocardial tissue perfu-
sion [4] and myocardial salvage [5]. The most solid
evidence on the predictive value of ST-segment reso-
lution has come from thrombolytic studies. Primary
percutaneous coronary intervention (PPCI) studies
have also suggested the existence of an association
between ST-segment resolution and improved sur-
vival [3, 6–10]. There are, however, great differenc-
es between thrombolysis and PPCI in terms of
degree of restoration of epicardial blood flow (60%
with thrombolysis vs close to 95% with PPCI) and
the speed of blood flow restoration. Furthermore,
PPCI studies that have investigated the association
between the degree of ST-segment resolution
and outcome have had great differences in the tim-
ing of ST-segment resolution analysis, have used
various cut-offs for the assessment of ST-segment
recovery, and in most studies ST-segment resolu-
tion analysis was not performed in an independent
electrocardiographic (ECG) core laboratory [3, 7–
–9]. The limited value of ST-segment resolution to
predict myocardial salvage in anterior infarction
[11], uncertainty about the best cut-off point crite-
ria for ST-segment resolution [12] and important-
ly, the contradictory nature of the most recent evi-
dence on the association between ST-segment re-
covery and prognosis [10, 13], show that the clinical
value of ST-segment resolution after PPCI remains
unclear.
The aim of the present study was to assess
whether the degree of ST-segment resolution is
a predictor of long-term mortality in patients with
STEMI treated with PPCI.
Methods
Patients
The study included a consecutive series of
900 patients with acute STEMI who presented within
the first 24 h after symptom onset and who were
treated with PPCI between January 2002 and Decem-
ber 2007 in the Deutsches Herzzentrum in Munich.
The diagnosis of STEMI required: chest pain lasting
≥ 20 min and ST-segment elevation of ≥ 1 mm in
at least two extremity ECG leads or ≥ 2 mm in at
least two contiguous precordial leads or left bundle
branch block (LBBB) of new onset. The diagnosis
was confirmed with coronary angiography at the
time of PPCI. The source sample out of which the
study patients were obtained consisted of 1,026
patients. Patients with mechanical failures (n = 24),
patients with missing ECG or with technically in-
adequate recordings (n = 45) and those presenting
with LBBB, even though the diagnosis of acute MI
was established based on clinical and biomarker data
and confirmed by angiography (n = 57) were ex-
cluded. Patients with cardiogenic shock were also
excluded. Thus, 900 patients with STEMI and tech-
nically adequate ECG before and 90–120 min after
PPCI were included in this study. All patients gave
informed consent for participation in the study. The
study was conducted according to the principles of
the Declaration of Helsinki and approved by the
institutional ethics committee.
ST-segment resolution
All included patients had technically adequate
12-lead ECG, before and 90–120 min after the first
balloon inflation. The sum of ST-segment elevation
was measured 20 ms after the end of the QRS com-
plex in: leads I, aVL, and V1 through V6 for anterior
infarction; leads II, III, aVF for inferior infarction
and leads V5 to V6 for lateral infarction. The ST-
-segment elevation resolution was calculated as the
initial sum of ST-segment elevation minus the sum
of ST-segment elevation on the second ECG divid-
ed by the initial sum of ST-segment elevation and
expressed as a percentage. Patients were divided
into three groups according to the degree of ST-
-segment resolution: < 30% (no resolution); 30%
to £ 70% (partial resolution); and > 70% (complete
resolution). Analysis of ST-segment elevation reso-
lution was performed in the ECG core laboratory
by personnel unaware of reperfusion status or fol-
low-up information.
Angiographic examination and definitions
Coronary angiography was performed according
to standard criteria. Offline analysis of digital
angiograms was performed in the core laboratory
using an automated edge detection system (CMS,
Medis Medical Imaging Systems, Neuen, the Nether-
lands) by personnel blinded to the clinical diagno-
sis. Primary PCI (mostly with stent implantation)
and periprocedural care were performed according
to the standard criteria. Bare metal stents were
mostly used. Antiplatelet therapy consisted of clo-
pidogrel (600 mg as a loading dose followed by
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75 mg/day for a minimum of four weeks and a ma-
ximum of six months) and aspirin (200 mg/day in-
definitely).
Epicardial blood flow in the infarct-related artery
and myocardial perfusion grade were graded accord-
ing to the Thrombolysis in Myocardial Infarction
(TIMI) group definitions: TIMI 0, no reperfusion;
TIMI 1, penetration without perfusion; TIMI 2, par-
tial reperfusion; TIMI 3, complete perfusion. Myo-
cardial perfusion grade (MPG) was defined as fol-
lows: MPG 0, contrast fails to enter the microvas-
culature; MPG 1, contrast slowly enters but fails to
exit the microvasculature; MPG 2, delayed entry
and exit of contrast of dye from the microvascula-
ture; and MPG 3, normal entry and exit of dye from
the microvasculature [14]. The left ventricular ejec-
tion fraction (LVEF) was measured on left ventric-
ular angiograms using the area-length method [15].
Collateral circulation was quantified according to
Rentrop’s classification [16]. Glomerular filtration
rate (GFR) was calculated using the Cockroft-Gault-
-formula [17]. Severity of heart failure in the acute
stage of STEMI was assessed according to the Kil-
lip classification [18].
End points and follow-up
The primary end point of the study was five-
-year mortality. Non-fatal MI and target lesion re-
vascularization at five years and LVEF at six months
were secondary end points. The follow-up informa-
tion was collected by a phone call at 30 days, a visit
at six months, a phone call at one year and annual
phone calls thereafter. Patients who had cardiac
complaints underwent complete clinical, ECG, and
laboratory evaluation. Information on deaths was
obtained from hospital records, death certificates or
phone contact with relatives of the patient or the
patient’s referring physician. The follow-up infor-
mation was collected by personnel unaware of the
status of reperfusion or ST-segment resolution at
the end of the PPCI procedure. As standard prac-
tice in our institution, all patients were scheduled
to undergo coronary angiography six months after
the procedure or whenever they showed symptoms
or signs of myocardial ischemia.
Statistical analysis
The normality of data distribution was analyzed
using a Kolmogorov-Smirnov test. Data is presented
as median (with 25th–75th percentiles), mean ± SD
or counts and proportions (percentages). Categori-
cal data was compared using a c2 test. Continuous
data was compared using a Wilcoxon rank-sum test.
Five-year mortality was estimated using the Ka-
plan-Meier method and log rank test. Linear regres-
sion analysis was used to determine intra- and
interobserver variability in the measurement of
ST-segment resolution. A multiple linear regres-
sion model was used to identify independent pre-
dictors of ST-segment resolution (entered in the
model as a continuous variable). All variables of
Tables 1 and 2 were entered into the model.
Univariable and multivariable Cox proportional ha-
zards models were used to assess the association
between ST-segment resolution degree and five-
-year mortality. All variables (Tables 1 and 2) and
ST-segment resolution (dichotomized at < 30%,
30% to £ 70% and > 70% resolution categories)
were entered into the univariable Cox proportional
hazards model with five-year mortality as a depen-
dent variable. To identify independent correlates of
five-year mortality, variables that showed a signifi-
cant association with mortality in the univariable
Cox model and ST-segment resolution (dichoto-
mized at < 30%, 30% to £ 70% and > 70% resolu-
tion groups) were entered into the multivariable
Cox proportional hazards model. All analyses were
performed using S-plus statistical package (S-
-PLUS, Insightful Corp, Seattle, WA, USA). A two-




Baseline demographic and clinical characteris-
tics are shown in Table 1. There were 263 (29.0%)
patients with ST-segment resolution < 30%, 356
(40.0%) patients with ST-segment resolution be-
tween 30% and £ 70%, and 281 (31.0%) patients
with ST-segment resolution > 70%. Patients in the
group with ST-segment resolution > 70% featured
a higher proportion of women, a smaller proportion
of anterior infarct location, lower levels of C-reac-
tive protein, a higher LVEF and presented earlier
to hospital compared to other groups. Moreover,
groups appear to differ regarding the values of GFR.
Angiographic data is shown in Table 2. The group
with ST-segment resolution > 70% had a lower
proportion of patients with left anterior descendent
artery occlusion and higher rates of post-interven-
tional TIMI flow grade 3 and of MPG of 3. The re-
maining characteristics did not differ significantly
between the groups. Overall median (interquartile
range) time-to-admission and door-to balloon inter-
vals were 4.0 (2.0 to 8.6) h and 1.25 (0.87 to 1.75) h,
respectively. In a sample of 50 patients, the intra-
observer (linear regression coefficient R = 0.96)
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and interobserver (linear regression coefficient
R = 0.92) variability in the ST-segment resolution
measurement were low.
Predictors of ST-segment resolution
Multiple linear regression model identified
anterior infarct location (beta coefficient = –0.203;
p < 0.001), time-to-admission interval (beta coeffi-
cient = –0.015; p < 0.001), GFR (beta coefficient =
= –0.001; p = 0.038) and body mass index (beta co-
efficient = 0.012; p = 0.014) as independent corre-
lates of ST-segment resolution. Female sex (beta
coefficient = 0.071; p = 0.07) and current smoking
(beta coefficient = 0.066; p = 0.08) were close to
reaching statistical significance.
ST-segment resolution and clinical events
The median follow-up (25th; 75th percentile) was
4.0 (2.1–4.9) years. There were 62 deaths during
the follow-up: 17 deaths in the group with ST-seg-
ment resolution < 30%, 29 deaths in the group with
ST-segment resolution 30% to £ 70%, and 16 deaths
in the group with ST-segment resolution > 70%
(Kaplan-Meier estimates of mortality: 8.3%, 11.5%
and 6.8%, respectively; odds ratio [OR] = 0.87, 95%
confidence interval [CI] 0.43–1.77; p = 0.706 for
ST-segment resolution > 70% vs ST-segment reso-
lution < 30%; Fig. 1). Thirty-nine deaths were of
cardiac origin: 12 deaths in the group with ST-seg-
ment resolution < 30%, 20 deaths in the group with
ST-segment resolution 30% to £ 70% and seven
deaths in the group with ST-segment resolution
> 70% (Kaplan-Meier estimates of cardiac mortali-
ty: 5.9%, 7.4% and 2.8%, respectively; OR = 0.53,
95% CI 0.21–1.39; p = 0.188 for ST-segment reso-
lution > 70% vs ST-segment resolution < 30%).
There was a trend for lower cardiac mortality in
patients with complete (> 70%) ST-segment reso-
Table 1. Baseline characteristics in groups according to ST-segment resolution after percutaneous
coronary intervention.
Characteristic ST-segment resolution P
< 30%  30% to £ 70% > 70%
(n = 263) (n = 356) (n = 281)
Age [years] 61.7 [49.8–70.2] 60.2 [50.8–70.2] 62.0 [53.6–72.4] 0.146
Women 49 (18.6) 74 (20.8) 85 (30.2) 0.002
Diabetes 58 (22.1) 55 (15.4) 47 (16.7) 0.089
Arterial hypertension 173 (65.8) 243 (68.3) 201 (71.5) 0.348
Body mass index [kg/m2] 26.1 [24.1–28.3] 26.2 [24.1–28.7] 26.2 [24.3–28.6] 0.664
Hypercholesterolemia 134 (50.9) 181 (50.8) 151 (53.7) 0.730
Current smoker 110 (41.8) 159 (44.7) 128 (45.5) 0.657
Prior myocardial infarction 29 (11.0) 31 (8.7) 33 (11.7) 0.415
Prior coronary artery bypass surgery 6 (2.3) 8 (2.3) 11 (3.9) 0.376
Killip class: 0.120
   I 204 (77.6) 264 (74.2) 212 (75.4)
   II 45 (17.1) 83 (23.3) 54 (19.2)
   III 14 (5.3) 9 (2.5) 15 (5.3)
Infarct location: < 0.001
   Anterior 162 (61.6) 197 (55.3) 72 (25.6)
   Inferior 75 (28.5) 129 (36.2) 180 (64.1)
   Lateral 26 (9.9) 30 (8.5) 29 (10.4)
C-reactive protein [mg/L] 5.0 [0.0; 12.8] 3.6 [0.0; 9.6] 2.6 [0.0; 7.2] 0.005
Glomerular filtration rate [mL/min] 88.5 [68.1; 114.8] 88.0 [66.8; 109.3] 84.1 [61.3; 103.9] 0.033
Peak creatine kinase MB [UI/L] 150.0 [68.0; 265.0] 144.0 [73.8; 308.3] 125.0 [65.0; 259.0] 0.149
Peak troponin T [µg/L] 3.9 [1.7; 7.4] 4.3 [1.9; 8.0] 3.6 [1.7; 6.6] 0.390
Left ventricular ejection fraction [%] 48.0 [39.1–54.0] 49.0 [41.3–55.0] 51.0 [44.0–57.0] 0.001
Time-to-admission interval [h] 6.9 [2.4; 12.1] 3.7 [2.0; 7.0] 3.1 [1.6; 5.3] < 0.001
Sum of ST-segment elevation [mm] 6.3 ± 4.0 9.3 ± 6.5 9.4 ± 8.2 < 0.001
ST-segment resolution [%] 3.0 [–24.9–18.5] 50.5 [40.6–60.7] 86.4 [77.4–100.0] < 0.001
Data is median [interquartile range], mean ± SD or counts (%)
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lution vs those with incomplete (£ 70%) ST-se-
gment resolution (Kaplan-Meier estimates of five-
-year mortality 2.8% [seven deaths] and 6.8%
[32 deaths], respectively; OR = 0.48, 95% CI 0.21–
–1.07, p = 0.07).
Non-fatal myocardial infarction occurred in
24 patients: eight infarctions in the group with ST-
-segment resolution < 30%, 14 infarctions in the group
with ST-segment resolution 30% to £ 70%, and two
infarctions in the group with ST-segment resolu-
tion > 70% (Kaplan-Meier estimates of infarction
occurrence: 3.6%, 4.7% and 1.0%, respectively;
odds ratio [OR] = 0.22, 95% CI 0.05–1.08; p = 0.088
for ST-segment resolution > 70% vs ST-segment
resolution < 30%). Target lesion revascularization
was required in 204 patients: 60 (25.5%) revascu-
Table 2. Angiographic characteristics in groups according to ST-segment resolution after percutaneous
coronary intervention.
Characteristic ST-segment resolution P
< 30% 30% to £ 70% > 70%
(n = 263) (n = 356) (n = 281)
Door-to-balloon time [h] 1.25 [0.89; 1.82] 1.23 [0.85; 1.67] 1.33 [0.92; 1.83] 0.251
Occluded coronary artery: < 0.001
Left main 1 (0.4) 0 (0.0) 1 (0.4)
Left anterior descending 166 (63.1) 200 (56.2) 72 (25.6)
Left circumflex 19 (7.2) 36 (10.1) 42 (16.0)
Right coronary artery 73 (27.8) 116 (32.6) 160 (56.9)
Bypass graft 4 (1.5) 4 (1.1) 6 (2.1)
Number of affected coronary arteries: 0.089
1 106 (40.3) 141 (39.6) 92 (32.7)
2 83 (31.6) 119 (33.4) 87 (31.0)
3 74 (28.1) 96 (27.0) 102 (36.3)
Multivessel disease 157 (60.0) 215 (60.4) 189 (67.3) 0.119
Pre-intervention TIMI flow grade: 0.471
0 127 (48.3) 182 (51.1) 123 (43.8)
1 31 (11.8) 40 (11.2) 45 (16.0)
2 60 (22.8) 76 (21.3) 68 (24.2)
3 45 (17.1) 58 (16.3) 45 (16.0)
Post-intervention TIMI flow grade: 0.019
0 8 (3.0) 4 (1.1) 5 (1.8)
1 6 (2.3)  8 (2.2) 5 (1.8)
2 35 (13.3) 34 (9.6) 14 (5.0)
3 214 (81.4) 310 (87.1) 257 (91.4)
Collateral grade: 0.908
0 197 (74.9) 255 (71.6) 208 (74.0)
1 37 (14.1) 62 (17.4) 44 (15.7)
2 21 (8.0) 26 (7.3) 22 (7.8)
3 8 (3.0) 13 (3.7) 7 (2.5)
Myocardial blush grade: < 0.001
0  62 (23.6) 72 (20.2) 46 (16.4)
1 28 (10.6) 28 (7.9) 9 (3.2)
2 46 (17.5) 57 (16.0) 32 (11.4)
3 127 (48.3) 199 (55.9) 194 (69.0)
Type of intervention: 0.249
Stenting 231 (87.8) 324 (91.0) 258 (91.8)
Balloon angioplasty 32 (12.2) 32 (0.0) 23 (8.2)
Data is median [25th, 75th percentiles] or number of patients (%); TIMI — thrombolysis in myocardial infarction
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larizations in the group with ST-segment resolution
< 30%, 87 (26.9%) revascularizations in the group
with ST-segment resolution 30% to £ 70%, and
57 (22.6%) revascularizations in the group with
ST-segment resolution > 70% (p = 0.423). Major
adverse events (i.e. all-cause death, non-fatal MI
or target lesion revascularization) occurred in
261 patients: 74 (31.6%) adverse events in the group
with ST-segment resolution < 30%, 115 (37.0%)
adverse events in the group with ST-segment res-
olution 30% to £ 70%, and 72 (28.2%) adverse
events in the group with ST-segment resolution
> 70% (p = 0.204).
The association between ST-segment resolu-
tion and mortality was also tested in the univari-
able and multivariable Cox proportional hazards
model (see methods for variables entered into the
models). Independent correlates of mortality from
the univariable Cox model are shown in Table 3.
ST-segment resolution was not independently as-
sociated with mortality either in the univariable
(hazard ratio [HR] = 0.88, 95% CI 0.46–1.67, p =
= 0.695 for ST-segment resolution > 70% vs ST-
-segment resolution < 30%) or the multivariable
Cox model (HR = 0.91, 95% CI 0.61–1.33, p = 0.607
for ST-segment resolution > 70% vs ST-segment
resolution < 30%).
ST-segment resolution and six-month
left ventricular ejection fraction
Follow-up angiography was performed in 690
(77%) patients with no difference between groups
(p = 0.181). In the groups with ST-segment reso-
lution < 30% (n = 191), 30% to 70% (n = 281) and
> 70% (n = 218), the six-month LVEF (median
[25th–75th percentiles]) was 53.0% [45.0%; 60.0%],
51.0% [44.0%; 58.0%] and 55.0% [49.0%; 60.0%],
respectively; p = 0.011]. The difference between
the six-month and the baseline LVEF (delta LVEF)
was 4.0% [–1.0% to 11.0%] in the group with ST-
-segment resolution < 30%, 2.0% [–2.2 to 9.0%] in
the group with ST-segment resolution 30% to
£ 70% and 1.6% [–2.0% to 10.0%] in the group
with ST-segment resolution > 70% (p = 0.082)
demonstrating no impact of ST-segment resolution
on six-month LVEF.
Discussion
The main findings of this study can be summa-
rized as follows: 1) In patients with STEMI treated
with PPCI, the degree of ST-segment elevation
resolution in ECG recorded 90–120 min after the
first balloon inflation did not predict long-term all-
cause mortality; 2) The degree of ST-segment res-
olution after PPCI in patients with STEMI had no
impact on LVEF at six-months or on the occurrence
of non-fatal MI or the need for target lesion revas-
cularization up to five years after PPCI.
Previous studies of ST-segment resolution af-
ter PPCI have demonstrated an association between
the degree of ST-segment resolution and clinical
outcome [19]. These studies, however, were cha-
racterized by considerable methodological dispari-
ty in nearly all aspects of ST-segment resolution,
which make their joint consideration rather prob-
lematic. The most recent evidence regarding the
prognostic impact of ST-segment resolution after
Figure 1. Kaplan-Meier curves of five-year survival in groups with ST-segment resolution (ST-res) < 30%, 30% to
£ 70% and > 70%.
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PPCI has been contradictory [10, 13]. A recent ana-
lysis of 4,866 patients in the Assessment of Pexel-
izumab in Acute Myocardial Infarction (APEX-AMI)
trial demonstrated that the degree of ST-segment
resolution 30 min (median 32 min) after PPCI was
closely associated with the rates of 90-day death or
composite end point of 90-death, heart failure or
shock [10]. It is worth noting that all six different
methods used to calculate ST-segment recovery
provided strong prognostic information regarding
the clinical outcome [10]. Contrary to the findings
of the APEX-AMI trial, a recent report from the
DANish Acute Myocardial Infarction-2 (DANAMI-2)
trial came to the opposite conclusions [13]. The
DANAMI-2 trial analysis included 1,421 patients
treated with fibrinolysis or PPCI in whom the de-
gree of ST-segment resolution at 90 min and 4 h
after PPCI was assessed. In groups with no (< 30%),
partial (30% to 70%), and complete (> 70%) ST-
-segment resolution, there were significant differ-
ences in 30-day and 4.2-year mortality in patients
treated with fibrinolysis, but not in those treated
with PPCI. The authors concluded that ST-segment
resolution remains an important predictor of prog-
nosis after fibrinolysis, but may be overemphasized
as a surrogate end point after PPCI [13].
In the present study, we also could not find
an association between the degree of ST-segment
resolution in the ECG recorded 90–120 min after
a PPCI procedure and all-cause mortality, non-fa-
tal MI or the need for repeat revascularization up
to five years after PPCI. Similarly, we could not
find any association between the degree of ST-seg-
ment resolution in the 90–120-min ECG and LVEF
six months after a PPCI procedure. In this regard,
our results support those of the DANAMI-2 trial
and provide further proof of the limited value of
ST-segment resolution after PPCI in patients with
STEMI, at least if ST-segment resolution analy-
sis is based on ECG obtained 90 min (or more)
after PPCI.
The exact reasons for concordance of the re-
sults with the DANAMI-2 trial [13] and the discor-
dance with the APEX-AMI trial [10] are not known.
However, a tentative explanatory hypothesis may
be raised. Despite the fact that ST-segment eleva-
tion was recognized as a sign of coronary occlusion
more than 90 years ago by Pardee [20], the under-
lying mechanisms of ST-segment elevation and reso-
lution in the course of myocardial ischemia or ne-
crosis remain unclear. As previously demonstrat-
ed experimentally by Kleber et al. [21], ST-segment
elevation becomes maximal 10–15 min after coro-
nary occlusion and declines afterwards to almost
complete resolution in the center of the ischemic
zone at 2 h of coronary occlusion.
According to current knowledge, ischemia
leads to an increase in extracellular potassium con-
centration (due to ischemia-induced intracellular
potassium loss) leading to a current of injury flow-
Table 3. Correlates of five-year mortality and hazard ratios calculated by univariable Cox proportional
hazards model.
Variable Hazard ratio [95% CI] P
Age (for 10-year increase) 2.32 [1.86–2.90] < 0.001
Female sex 2.21 [1.32–3.70] 0.003
Diabetes 2.18 [1.27–3.75] 0.004
Body mass index (for 5 kg/m2 increase) 0.66 [0.46–0.95] 0.025
Previous myocardial infarction 1.98 [1.03–3.79] 0.040
Anterior infarct location 1.76 [1.06–2.94] 0.030
Killip class (for 1 class increase) 2.24 [1.58–3.15] < 0.001
Glomerular filtration rate (for 30 mL/min decrease) 2.82 [2.06–3.84] < 0.001
Baseline C-reactive protein (for 5 mg/L increase) 1.05 [1.03–1.07] 0.019
Time-to-admission interval (for 1 h increase) 1.04 [1.01–1.08] 0.023
Left ventricular ejection fraction (for 10% decrease) 1.40 [1.11–1.75] 0.003
Multivessel disease (vs single vessel) 2.14 [1.18–3.88] 0.013
Collateral circulation (for 1 class increase) 0.65 [0.43–0.99] 0.044
Post-intervention TIMI grade (for 1 grade decrease) 1.57 [1.16–2.13] 0.003
Myocardial blush grade (for 1 grade decrease) 1.33 [1.10–1.61] 0.002
ST-segment resolution (for > 70% vs < 30% resolution) 0.88 [0.46–1.67] 0.695
CI — confidence interval; TIMI — thrombolysis in myocardial infarction
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ing from ischemic to normal myocardium which
provides the electrophysiological basis of ST-seg-
ment elevation in the ECG. The difference in the
transmembrane potential between ischemic and
normal myocardium build up only the electromotive
force of the current of injury [22]. In addition, the
flow of current requires a low-resistance pathway
or intact (at least functional) cell-to-cell coupling
[22]. Upon brisk restoration of massive coronary
blood flow in the infarct-related artery by PPCI,
there is an abrupt increase in intracellular Ca2+. The
excess of Ca2+ may damage cell-to-cell communi-
cation and lead to cellular uncoupling due to calci-
um induced inhibition of gap junction conductance
[23]. As a consequence, resistance to current flow
is abruptly increased which leads to an attenuation
of the current of injury and a decline in the ST-seg-
ment elevation in the ECG. Moreover, the reper-
fusion-accentuated excess of intracellular Ca2+ in-
vigorates cell death by causing hypercontracture of
cardiomyocytes which almost exclusively occurs
within the first minutes of reperfusion [24]. Reper-
fusion-induced cell death and cell-to-cell uncoupling
may markedly attenuate the current of injury
through reducing its driving force (cell death) and
increased resistance in its pathway of flowing.
These two factors may cause a quick ST-segment
resolution in the ECG, which is not due to myocar-
dial salvage. Thus, it is reasonable to summarize that
ST-segment resolution after PPCI reflects not only
myocardial salvage [5], which reduces the current
of injury by restoring the transmembrane potential
of salvaged cells, but also reperfusion-induced ac-
centuation of cardiomyocyte death and cell-to-cell
uncoupling.
The timing of ST-segment resolution analysis
may provide a further explanation of discrepancies
between the studies. In the present study and the
DANAMI-2 study [13], the ST-segment resolution
analysis was performed late (more than 90 min) af-
ter PPCI. Conversely, in the APEX-AMI trial [10],
the ST-segment resolution analysis was performed
early (median 32 min) after PPCI. Based on the
results of these studies, it may be hypothesized that
an early ST-segment analysis after PPCI, as carried
out in the APEX-AMI trial [10] and other studies
[25], may reflect more closely the myocardial sal-
vage, known to be a predictor of improved survival
after PPCI [26]. In late ST-segment analyses, like
the ones performed in the DANAMI-2 trial [13] and
the present study, the prognostic power of ST-seg-
ment resolution related to myocardial salvage may
be offset by components of ST-segment resolution
related to reperfusion-induced cell death and da-
mage of cell-to-cell coupling. Further studies are
needed to corroborate this hypothesis.
Limitations of the study
The present study has several limitations. Se-
rial ECG recordings were not performed. As a con-
sequence, the speed of ST-segment resolution
could not be assessed. Although data was prospec-
tively collected, the ECG for ST-segment resolu-
tion measurements were retrospectively analyzed.
The data on LVEF was available only in patients in
whom repeat angiography was performed (77%).
Due to the time of patient recruitment for the
present study, the age and gender-specific criteria
of the ST-segment analysis recommended by Ameri-
can Heart Association/American College of Cardio-
logy Foundation/Heart Rhythm Society [27] were
not used for the diagnosis of STEMI. Although time-
-to-admission and door-to-balloon intervals were
within the range of previous studies in patients with
STEMI, the inclusion of patients up to 24 h follow-
ing symptom onset may indicate that some patients
may be included after the infarction process has
already completed, at least in terms of ST-segment
dynamics. Although the present study did not de-
monstrate an association between the degree of
ST-segment resolution and five-year mortality, fac-
tors such as younger age of patients, small infarcts,
low event rate, long time-to-treatment interval and
intervention of other confounding factors during the
five-year follow-up may have minimized the predic-
tive value of ST-segment resolution. Since long-
-term mortality may be predicted by multiple factors,
some of them unrelated to reperfusion, the power
of reperfusion markers to predict long-term mor-
tality may be attenuated.
Conclusions
In patients with STEMI undergoing PPCI, ST-
-segment resolution in ECG recorded 90–120 min
after the initiation of PPCI (first balloon inflation)
did not predict long-term mortality, non-fatal MI
or target lesion revascularization. The degree of
ST-segment resolution was not associated with
an improvement of LVEF at six months after
PPCI. Further studies are needed to assess the
optimal timing of ST-segment resolution and its
prognostic impact in patients with STEMI after
PPCI.
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